Thu, Feb 26, 2015, 7:00 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Antares Pharma Inc. Message Board

fda_approval_trading 31 posts  |  Last Activity: Jan 11, 2015 10:00 AM Member since: Sep 23, 2013
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Pharma Ad Guy - Exenatide (con't)

    by tdpeterson123 Jan 9, 2015 12:51 PM
    fda_approval_trading fda_approval_trading Jan 11, 2015 10:00 AM Flag

    hey TD. lot of good info.

    why is no one here talking about Otrexup Rx any more? is it trending well? or is it stagnant and no one cares any more? QST data in Feb right?

    trying to do valuation of this co.

    i had thought Otrexup was THE core product...but seems sale trend for O. is not what previous Ceo had predicted...

    any more info?

  • fda_approval_trading fda_approval_trading Jan 9, 2015 5:20 PM Flag

    your ono and only post in past 10 yrs? and it's FMI recommendation. why is this down so much from IPO - was $40+ not long ago.

    vol is low too

  • Reply to

    Option Super Bargain

    by geringerart Jan 9, 2015 2:25 PM
    fda_approval_trading fda_approval_trading Jan 9, 2015 2:40 PM Flag

    i don't see that geringerart... not even close

  • Reply to

    Support and Resistance, Wednesday 1/7/15

    by mikerconfer Jan 7, 2015 9:42 AM
    fda_approval_trading fda_approval_trading Jan 7, 2015 11:31 AM Flag

    Mike

    I believe today's action is breakout? or do we need to close above certain level to be so? we seem to have broken out of the wedge we've been in for few months. as of yesterday's close , we broke out I think

    vol is good too...

  • Reply to

    Uncertainty Brings Opportunity?

    by geringerart Dec 23, 2014 1:48 PM
    fda_approval_trading fda_approval_trading Dec 23, 2014 3:24 PM Flag

    thanks geringart,
    I have been holding entire year (options and stock).. losing quite a bit so far.. have time of course, but surely have a lot of 'could've' and 'should've' this year.

    exclusions have really been my biggest concern - not that I doubt CEO's ability to overcome it, but the fact that we have to keep raising prices of our drugs... I don't like that being our biz model. love Vidara acquisition and Actimmune...

    I am looking forward to a much more of a orphan drug company that is already profitable and w/ solid revenue base in the coming year or two

  • Reply to

    Uncertainty Brings Opportunity?

    by geringerart Dec 23, 2014 1:48 PM
    fda_approval_trading fda_approval_trading Dec 23, 2014 1:55 PM Flag

    geringerart

    it's almost always half full view, if one is in the money... if one is under water as some of us here, it's hard to be that way, at least without taking few deep breaths..

    in years down the road, I am sure we are not going to be 12.34$ stock. surely, no?

    although I do fear of a major stock correction within 3 months..

    in 3 years, even that kind of correction won't matter

  • fda_approval_trading by fda_approval_trading Dec 23, 2014 9:50 AM Flag

    yesterday's implication sunk in I guess. it's not good for the sector. ABBV tactic hurt the sector for months to come... I have some words to describe them but yahoo won't print it anyway

  • fda_approval_trading by fda_approval_trading Dec 22, 2014 4:47 PM Flag

    is due to "bad news". This is most likely not true. Data may be received by now internally and undergoing analysis, and they will release PR sometime first few weeks of new year.

    personally I believe recent selling is just 'selling' with domino effect when pps can't get above certain level - here ($8 here). once we couldn't get over that level, ppl sold off.. then more ppl sold off... and here we are today. in the past 1 month, we went from $7 to $8 and now back to $7 (more or less).

    nothing in this indicates leaked data... if it were, you would get a lot more selling and volume than what we got. a lot more...

    also as ppl realized that data wouldn't be coming out this month, they sold... short term traders anyway...

    my sense is between mid Jan - mid Feb we get the results.

    there are 5 data prints in 2015.. 2 due in Q1 2015.. only takes couple of good reads and this thing 'could' be in the 20-30 range, given float and low valuation of 100M at the moment. good data could propel this to become a 2-3 bagger in 1 quarter.

    I am sure that's what everyone is playing this for (on the long side).

    for shorts, I don't get it. pps could go down another 1-2$ but why short a 100M company with 5 data coming? so many better shorts out there. seems to me shorts playing wrong stock for many reasons

  • fda_approval_trading fda_approval_trading Dec 22, 2014 12:40 PM Flag

    yea I do not like this at all for the bio sector ... I dislike Cramer but he said this is a game changer and I think so too for future - will affect valuation, etc. for the sector/stocks like GILD and many others.

    not to mention our own exclusion issues. at least we have PME to offset some of the loss in sales.

    sure puts a damper to the bio rally.. GILD is down huge but still not tempted to buy it in the 94 range. maybe 85.. prob not until things settle

  • Reply to

    Psychotic Chart

    by geringerart Dec 17, 2014 2:18 PM
    fda_approval_trading fda_approval_trading Dec 19, 2014 4:24 PM Flag

    weekly chart is very bullish now after today.

    my sense is barring market meltdown next week, we will grind up next two weeks into $14's. with good Rx in Jan-Feb, we should be $15's and base until ER and/or acquisition news, etc.

    IF market is still bullish. It has gone up 800 points in 3 days. a bit overly done. IBB new all time high today but low volume.

    Monday is key - market needs follow through. if we don't, I suspect we re-test high 12s and low 13's again.

    but sooner or later, I think we will hit 14 within next days/week

  • fda_approval_trading fda_approval_trading Dec 19, 2014 1:43 PM Flag

    another attempt to break out

  • Reply to

    ibb and markets way up but we are not what gives

    by nzvt Dec 18, 2014 11:03 AM
    fda_approval_trading fda_approval_trading Dec 18, 2014 4:29 PM Flag

    I said mid 12 to mid 13. that's $1 spread. that to me is a good trading stock. one could have consistently made 50 to 75 cents on this stock for past 6 wks.

    I am not one of them

  • Reply to

    ibb and markets way up but we are not what gives

    by nzvt Dec 18, 2014 11:03 AM
    fda_approval_trading fda_approval_trading Dec 18, 2014 4:16 PM Flag

    i agree, but w/ Dow up 750 points in 2 days NASDAQ up 200 points in 2 days; IBB up 15, we are barely $13 and a dime.

    at the same time, when market dropped 800 points, we didn't decline much at all, so it's just a stagnant stock from mid 12 to mid 13. good trading stock for traders.

    still not feeling confident we get over this hurdle until REAL material news or update on Rx for V, D etc in new year.

    all bears would want to see the proof in the pudding... that's Rx #s...

  • fda_approval_trading by fda_approval_trading Dec 12, 2014 5:16 PM Flag

    what's up w/ AH? up to 12.9...

    few K shares. strange but true.

    not that it's all that relevant in the big picture of things..

    can't find any news

  • Reply to

    Question for Mike

    by bender_32 Dec 10, 2014 3:14 PM
    fda_approval_trading fda_approval_trading Dec 11, 2014 4:58 PM Flag

    JR
    one of these days, the parabolic moves in AGIO, BLUE, KITE, etc. will all crash 50% or more.

    it just isn't sustainable.

    wait until market corrects.. those will be 1st ones to come back to earth.

    in the meantime, amazing how IBB and bio stocks have been up, up, up... (less HZNP).

  • Reply to

    Question for Mike

    by bender_32 Dec 10, 2014 3:14 PM
    fda_approval_trading fda_approval_trading Dec 11, 2014 4:13 PM Flag

    whole 1c gain ..!! wow.

    market doesn't know where it wants to go. down severely after hours (immediately after market closed, indices are down). not sure what to make of that.

    not feeling great about this. if market tanks again, we will go back to low end of trading range, AGAIN for the 1000th time.

    at some point, can our $12 support fail? need a drink

  • fda_approval_trading fda_approval_trading Dec 10, 2014 4:31 PM Flag

    Blue, why do you think our pps has stagnated a bit despite all the good data this week?

    I suppose we did move few points in the past weeks and we have priced in the good data?

    Still one of the cheapest valuation out there I believe.

    I hope we don't sell the co. anytime soon... wait til we achieve our own Billion + valuation before talking about a sale

  • Reply to

    Support and Resistance, Wednesday 12/10

    by mikerconfer Dec 10, 2014 10:40 AM
    fda_approval_trading fda_approval_trading Dec 10, 2014 2:39 PM Flag

    well. it stinks. market is rolling over.. SPY couldn't hold yesterday's low.. not boding well for days to come.

    I guess we will prob re-test 12 again..

    frustrating stock. all year...

  • Reply to

    Support and Resistance, Wednesday 12/10

    by mikerconfer Dec 10, 2014 10:40 AM
    fda_approval_trading fda_approval_trading Dec 10, 2014 12:20 PM Flag

    darn it.

    well, that didn't take long to reverse what appeared to be a break out..

    head fake again?

    I am beginning to dislike this stock... love the co.

  • Reply to

    Support and Resistance, Monday 12/8

    by mikerconfer Dec 8, 2014 10:52 AM
    fda_approval_trading fda_approval_trading Dec 9, 2014 4:03 PM Flag

    Mike, we closed below 13.5... but broke through 13.3's that was previous high in recent weeks.. some on twitter world are calling it breakout.

    whatever today was, it bodes well I think? don't know how we got 4M volume... not sure what happened there. I was tracking 2M or less.. then suddenly something happened.

    hope today was not a bear trap for the entire market.. market rallied crazily after gap down.

ATRS
2.65-0.01(-0.56%)Feb 26 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Herbalife Ltd.
NYSEThu, Feb 26, 2015 4:01 PM EST
Aruba Networks, Inc.
NASDAQThu, Feb 26, 2015 4:00 PM EST